Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.05% |
| 2 | Technology | 7.69% |
| 3 | Financials | 6.83% |
| 4 | Healthcare | 6.42% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DHBCU
2376
DELISTED
DHB Capital Corp. Unit
DHBCU
| $7.46M | ﹤0.01% |
755,308
-176,598
| -19% | -$1.75M |
|
2377
Clarivate
CLVT
$1.3B
| $7.45M | ﹤0.01% |
340,358
-976,776
| -74% | -$23.8M |
|
|
ACCD
2378
DELISTED
Accolade Inc
ACCD
| $7.44M | ﹤0.01% |
176,448
+6,890
| +4% | +$324K |
|
2379
PUT
Intercontinental Exchange
ICE
$91.2B
| $7.44M | ﹤0.01% |
64,800
-120,000
| -65% | -$14.2M |
|
2380
Trupanion
TRUP
$1.32B
| $7.43M | ﹤0.01% |
95,639
+52,309
| +121% | +$5.16M |
|
|
DCRN
2381
DELISTED
Decarbonization Plus Acquisition Corporation II Class A Common stock
DCRN
| $7.42M | ﹤0.01% |
752,054
+1,325
| +0.2% | +$13.1K |
|
2382
PUT
Cognizant
CTSH
$29.1B
| $7.42M | ﹤0.01% |
+100,000
| New | +$7.38M |
|
|
ETRN
2383
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $7.42M | ﹤0.01% |
731,678
-162,344
| -18% | -$1.43M |
|
|
SOHU
2384
Sohu.com
SOHU
$369M
| $7.38M | ﹤0.01% |
354,263
+329,529
| +1,332% | +$7.04M |
|
|
MDP
2385
DELISTED
Meredith Corporation
MDP
| $7.38M | ﹤0.01% |
132,446
+74,627
| +129% | +$3.26M |
|
|
SVC
2386
Service Properties Trust
SVC
$1.02B
| $7.38M | ﹤0.01% |
131,598
+125,859
| +2,193% | +$7.16M |
|
|
NOAC
2387
DELISTED
Natural Order Acquisition Corp. Common Stock
NOAC
| $7.36M | ﹤0.01% |
750,374
| – | – |
|
2388
PUT
Host Hotels & Resorts
HST
$15.3B
| $7.35M | ﹤0.01% |
+450,100
| New | +$7.3M |
|
|
CODX
2389
Co-Diagnostics
CODX
$8.45M
| $7.34M | ﹤0.01% |
25,150
+10,235
| +69% | +$2.99M |
|
2390
Clean Energy Fuels
CLNE
$359M
| $7.34M | ﹤0.01% |
900,659
+684,780
| +317% | +$5.45M |
|
2391
Petrobras Class A
PBR.A
$106B
| $7.33M | ﹤0.01% |
733,427
+431,349
| +143% | +$4.46M |
|
|
KYNB
2392
Kyntra Bio
KYNB
$32.2M
| $7.33M | ﹤0.01% |
28,692
+28,233
| +6,151% | +$10M |
|
2393
CXApp
CXAI
$8.55M
| $7.32M | ﹤0.01% |
14,737
| – | – |
|
|
ERF
2394
DELISTED
Enerplus Corporation
ERF
| $7.32M | ﹤0.01% |
914,930
+643,976
| +238% | +$4.01M |
|
2395
Check Point Software Technologies
CHKP
$14.3B
| $7.3M | ﹤0.01% |
64,601
-375,705
| -85% | -$45.8M |
|
|
CPAR
2396
DELISTED
Catalyst Partners Acquisition Corp. Class A Ordinary Share
CPAR
| $7.3M | ﹤0.01% |
+750,000
| New | +$7.28M |
|
|
DENN
2397
DELISTED
Denny's
DENN
| $7.29M | ﹤0.01% |
445,836
+80,384
| +22% | +$1.26M |
|
|
DRNA
2398
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $7.28M | ﹤0.01% |
361,222
+25,736
| +8% | +$711K |
|
2399
Impinj
PI
$5.17B
| $7.28M | ﹤0.01% |
127,363
-85,882
| -40% | -$4.39M |
|
2400
On Holding
ONON
$9.72B
| $7.27M | ﹤0.01% |
+241,374
| New | +$8.48M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.
By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.